News & Trends - MedTech & Diagnostics
Keyhole surgery in cervical cancer carries higher risk of death than open surgery

MedTech News: Minimally invasive techniques are increasingly common in cancer surgery. A recent trial has brought into question the safety of minimally invasive radical hysterectomy for cervical cancer.
In this systematic review and meta-analysis, researchers analysed the data from 15 previous studies, including a total of 9,499 patients, and say minimally-invasive ‘keyhole’ hysterectomies were associated with an increased risk of death among women with cervical cancer, compared with open surgery.
Women who underwent the keyhole procedure died sooner than those who underwent open surgery, and the disease was more likely to return, say the authors.
The pooled hazard of recurrence or death was 71% higher among patients who underwent minimally invasive radical hysterectomy compared with those who underwent open surgery (hazard ratio [HR], 1.71; 95% CI, 1.36-2.15; P < .001), and the hazard of death was 56% higher (HR, 1.56; 95% CI, 1.16-2.11; P = .004).
According to the authors, no association was found between the prevalence of robot-assisted surgery and the magnitude of association between minimally invasive radical hysterectomy and hazard of recurrence or death.
The findings support the survival benefits of undergoing full, open hysterectomy for early-stage cervical cancer.
Register & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
You may also like Key recommendations for data access to modernise Australia’s healthcare system post COVID-19 – Podcast
News & Trends - Pharmaceuticals

Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals

Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals

AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
More